Ubs Oconnor LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Ubs Oconnor LLC
- $1.46 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
70MCall Options Held
113KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA6.71MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$205 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$140 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$129 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$125 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.28B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...